In the tumor cells studied, Amblyomin-X blocked NFKB1 cleavage after proteasome inhibition, suggesting the inhibition of the NF-κB complex; thus, dynein function could not be related to its translocation to the nucleus. The gene discussed is NFKB1; the disease is neoplasm.